Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Current Urology Reports
|
November 16, 2004
New discoveries in the basic science understanding of Peyronie's disease
Mark Jalkut, Nestor Gonzalez-Cadavid, Jacob Rajfer
Reviews in Urology
|
September 21, 2006
Peyronie's Disease: A Review
Mark Jalkut, Nestor Gonzalez-Cadavid, Jacob Rajfer
Reviews in Urology
|
September 21, 2006
Future strategies for treating erectile dysfunction
Jacob Rajfer, Thomas Magee, Nestor Gonzalez-Cadavid
Current Urology Reports
|
October 22, 2005
Conservative management options for Peyronie's disease
Gregory S Jack, Nestor Gonzalez-Cadavid, Jacob Rajfer
The Journal of Sexual Medicine
|
January 18, 2006
Case report: Avoidance of palpable corporal fibrosis due to priapism with upregulators of nitric oxide
Jacob Rajfer, John L Gore, Jeffrey Kaufman, et al.
The Journal of Sexual Medicine
|
January 18, 2006
Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells
Dolores Vernet, Thomas Magee, Ansha Qian, et al.
The Journal of Sexual Medicine
|
April 15, 2010
Trauma, gender reassignment, and penile augmentation
David Ralph, Nestor Gonzalez-Cadavid, Vincenzo Mirone, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 7, 2003
Myostatin is a skeletal muscle target of growth hormone anabolic action
Wei Liu, Scott G Thomas, Sylvia L Asa, et al.
The Journal of Sexual Medicine
|
May 26, 2010
The management of Peyronie's disease: evidence-based 2010 guidelines
David Ralph, Nestor Gonzalez-Cadavid, Vincenzo Mirone, et al.
BJU International
|
September 25, 2007
Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection
Istvan Kovanecz, Amarnath Rambhatla, Monica G Ferrini, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Current Urology Reports
|
November 16, 2004
New discoveries in the basic science understanding of Peyronie's disease
Mark Jalkut, Nestor Gonzalez-Cadavid, Jacob Rajfer
Reviews in Urology
|
September 21, 2006
Peyronie's Disease: A Review
Mark Jalkut, Nestor Gonzalez-Cadavid, Jacob Rajfer
Reviews in Urology
|
September 21, 2006
Future strategies for treating erectile dysfunction
Jacob Rajfer, Thomas Magee, Nestor Gonzalez-Cadavid
Current Urology Reports
|
October 22, 2005
Conservative management options for Peyronie's disease
Gregory S Jack, Nestor Gonzalez-Cadavid, Jacob Rajfer
The Journal of Sexual Medicine
|
January 18, 2006
Case report: Avoidance of palpable corporal fibrosis due to priapism with upregulators of nitric oxide
Jacob Rajfer, John L Gore, Jeffrey Kaufman, et al.
The Journal of Sexual Medicine
|
January 18, 2006
Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells
Dolores Vernet, Thomas Magee, Ansha Qian, et al.
The Journal of Sexual Medicine
|
April 15, 2010
Trauma, gender reassignment, and penile augmentation
David Ralph, Nestor Gonzalez-Cadavid, Vincenzo Mirone, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 7, 2003
Myostatin is a skeletal muscle target of growth hormone anabolic action
Wei Liu, Scott G Thomas, Sylvia L Asa, et al.
The Journal of Sexual Medicine
|
May 26, 2010
The management of Peyronie's disease: evidence-based 2010 guidelines
David Ralph, Nestor Gonzalez-Cadavid, Vincenzo Mirone, et al.
BJU International
|
September 25, 2007
Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection
Istvan Kovanecz, Amarnath Rambhatla, Monica G Ferrini, et al.
Page
of 2